Recent Updates
Recently added Catalysts

Integer Holdings Corporation

ITGRFDA catalysts, PDUFA dates & pipeline intelligence
$126.97
▲ +0.27 · +0.21%

Financials

Last updated
Revenue
R&D Expenses
Operating CF
Total Assets
Total Liabilities
Equity
Shares Out.
D/E Ratio
Dilution Watch
Quarterly Cash
Unlock full ITGR financials and dilution scoring
Quarter by quarter figures, cash trend and dilution risk.
Institutional-grade data · Cancel anytime
52W LOW $66.5152W HIGH $133.06
Volume
798.71 K
Value Traded
101.45 M
Short % Float
11.82%
Days to Cover
4.3
+0.28%Week
+0.17%1 Month
+1.5%3 Month
+40.39%6 Month
-5.58%5 Year
+380.07%All Time

Cash Data

Unlock ITGR cash and runway
  • Monthly Burn
  • Burn Trend
  • Dilution Risk
  • SEC Filing

Key Stats

Market Cap
4.32 B
EPS (TTM)
3.05
P/E Ratio
41.63
Ent. Value
5.52 B
Total Shares
33.98 M
Float Shares
29.04 M
Insiders
14.60%
Institutions
108.12%

Upcoming Catalysts

FDA decisions, readouts and PDUFA dates · scored by probability of approval

Catalyst Drug / Treatment Stage Prob. of Approval Description Drug Type Therapeutic Area Source
Unlock every ITGR catalyst date and PoA score
Every FDA decision, readout and PDUFA date, with drug type, therapeutic area and a PoA score you can trade on.
Institutional-grade data · Cancel anytime
PoA blends historical approval base rates, trial design score and FDA review track record.

ITGR Catalyst Timeline

Dated clinical, regulatory and corporate events for Integer Holdings Corporation

Unlock the full ITGR catalyst timeline
Every PDUFA date, readout, approval and corporate move, tiered by market impact and updated daily.
Institutional-grade data · Cancel anytime

Past FDA Catalysts and PDUFA Decisions

How ITGR actually traded into and out of each decision

Date Drug Catalyst Stage Reaction Event Move % Best Trade %
No matching catalysts
Unlock all ITGR historical catalysts
Institutional-grade data · Cancel anytime
Reaction: 30 trading days around the event · Event Move: close to close on decision day · Best Trade: peak run-up from entry 10 days before the decision

Drug Pipeline Intelligence

No drug pipeline

Integer Holdings Corporation is a medical device company. The clinical trials it takes part in test other companies' drugs, so it has no drug pipeline of its own to score.

Clinical Trial Results

Readouts, endpoints and source filings for every ITGR program

Drug Name Indication Phase Date Trial Results SummaryTitleSource
Scroll for more · summaries link to the source press release
Unlock every ITGR trial readout
Institutional-grade data · Cancel anytime

Inside Trades

Unlock ITGR insider buying and selling
Monthly insider buys and sells against the stock price, with the insider sentiment reading.
Institutional-grade data · Cancel anytime
InsiderSideSharesPriceValueDate
Khales PaymanDirector, Officer (President & CEO)Option 2,514 64,368 held$0.00 10/24/2026
Unlock the full ITGR insider trade log
Institutional-grade data · Cancel anytime

Hedge Fund 13F Activity

Fund % of Portfolio Current MV Shares Owned Activity
PFM HEALTH SCIENCES, LP 1 % (-9.1 %) 11.84 M 126.67 K -6.23% ( -8.41 K)
Unlock every fund holding ITGR
Every 13F position with quarter over quarter share flow and average entry price.
Institutional-grade data · Cancel anytime
Unlock hedge fund flows in ITGR
Shares held by hedge funds each quarter, and who bought or sold.

Ownership Trends

Sign in to see ITGR ownership
Insider and institutional ownership, quarter by quarter.

ITGR Short Interest

Shares sold short, counted twice a month.

11.82%
Short % of Float
of tradable shares sold short
3.4M
Shares Sold Short
+5.6% vs prior count
4.3 Moderate
Days to Cover
trading days of normal volume to buy every short share back
802.0K
Avg Daily Volume
the average used for days to cover
Unlock ITGR short interest history
Two years of days to cover and shares sold short, with every count and its change.
Institutional-grade data · Cancel anytime

Options Data

Option Volume

Open Interest
Call OI
Put OI
Put-Call Ratio
OI 30-day avg
Today vs avg
Option Volume
Call Vol
Put Vol
Put-Call Ratio
Vol 30-day avg
Today vs avg

Option Chain Statistics

ExpiryCall VolPut VolVol P/CCall OIPut OIOI P/CIV CallIV Call OI-WtdIV Call Vol-WtdIV PutIV Put OI-WtdIV Put Vol-Wtd
2026-11-20
Unlock ITGR option chain statistics
Per-expiry call and put volume, open interest, put-call ratios and implied volatility.
Institutional-grade data · Cancel anytime

Real-Time Option Chain

CallsStrikePuts
LastVolOILastVolOI
No data available
Unlock the live ITGR option chain
Live calls and puts by strike: last price, volume and open interest for every expiry.
Institutional-grade data · Cancel anytime

Calls vs Puts by Expiry

CallsPutsLog scale
Unlock ITGR options analytics
Institutional-grade data · Cancel anytime

Competitive positioning

How ITGR ranks across every disease it competes in

Competitive Position is a premium feature
See how ITGR ranks against every competitor across each disease it develops in: phase, best drug, trials and likelihood of approval.
Start free trial

ITGR News

ITGR
Nov 17, 2026
ITGRGeneral
▲ +0.2%today

Integer Holdings Corporation Provides Notice of Make-Whole Fundamental Change, Fundamental Change and Right to Convert to Holders of its 2.125% Convertible Senior Notes due 2028 and 1.875% Convertible Senior Notes due 2030 in Connection with Completed Merger

Integer Holdings Corporation announced the completion of its merger with Armstrong Bidco, Inc. on November 17, 2026. Following the merger, holders of its convertible senior notes can convert their notes at an increased rate until January 8, 2027. The merger consideration for each outstanding share is $127.00 in cash.

Read more →
ITGR
Nov 17, 2026
ITGRGeneral
▲ +0.2%today

Integer Announces Completion of Acquisition by KKR

Integer Holdings Corporation has completed its acquisition by KKR, valued at approximately $5.7 billion. Stockholders will receive $127 per share in cash, and Integer's common stock will no longer be listed on the NYSE. The acquisition is expected to enhance Integer's growth strategy and innovation capabilities in the medical device sector.

Read more →
ITGR
Oct 29, 2026
ITGRGeneral

Integer Holdings Corporation Reports Third Quarter 2026 Results

Integer Holdings Corporation reported a 3.9% decline in sales for Q3 2026, totaling $450 million. GAAP operating income decreased by 50% to $28 million, while net income fell by 62% to $15 million. The company is currently awaiting the completion of its acquisition by KKR, which is expected to close by the end of 2026.

Read more →
ITGR
Oct 21, 2026
ITGRGeneral

Integer Holdings Corporation Stockholders Approve Proposals in Connection with KKR’s Proposed Acquisition of Integer

Integer Holdings Corporation's stockholders approved two key proposals related to KKR's proposed acquisition. At a special meeting, 99.95% of shares voted in favor of adopting the Merger Agreement. The second proposal, concerning executive compensation tied to the Transaction, also received majority approval. The acquisition is anticipated to close by the end of 2026, pending regulatory approvals.

Read more →
ITGR
Oct 2, 2026
ITGRGeneral

Integer Holdings Corporation Announces Conversion Period for 2.125% Convertible Senior Notes due 2028

Integer Holdings Corporation announced that its 2.125% Convertible Senior Notes due 2028 are now convertible from October 1, 2026, to December 31, 2026. The conversion is triggered by the stock price exceeding 130% of the conversion price. Holders can convert into cash or shares at a rate of 11.4681 shares per $1,000 of Notes.

Read more →
ITGR
Sep 30, 2026
ITGRGeneral

Integer Receives Early Termination of Hart-Scott-Rodino Waiting Period for Pending Acquisition by KKR

Integer Holdings Corporation announced the early termination of the Hart-Scott-Rodino waiting period for its acquisition by KKR. The merger, valued at $5.7 billion, requires stockholder approval and other regulatory conditions. A Special Meeting for stockholders is scheduled for October 21, 2026, to vote on the merger agreement.

Read more →
ITGR
Aug 3, 2026
ITGRGeneral

Integer Holdings Corporation Reports Second Quarter 2026 Results

Integer Holdings Corporation reported a 2.6% decline in sales to $464 million for Q2 2026, alongside a 42% drop in GAAP operating income to $35 million. The company announced a definitive agreement with KKR for an all-cash acquisition valued at $5.7 billion, offering shareholders $127 per share. Due to this pending transaction, Integer has withdrawn its financial outlook.

Read more →
ITGR
Aug 3, 2026
ITGRGeneral

Integer to Be Acquired by KKR in Transaction Valued at Approximately $5.7 Billion

KKR agreed to acquire Integer Holdings for $5.7 billion in an all-cash deal. Stockholders will receive $127 per share, a 51.8% premium over pre-review prices. The board unanimously approved the transaction following a strategic review. Integer expects to close the deal by year-end 2026, subject to regulatory approval.

Read more →
ITGR
Jul 2, 2026
ITGRConferences/Events

Integer Announces Conference Call to Discuss Second Quarter 2026 Results

Integer Holdings Corporation will host a conference call on August 6, 2026, to discuss its financial results for the second quarter ending July 3, 2026. The call will take place at 8 a.m. CT and will also cover other forward-looking information. A news release with the financial results will be issued prior to the call.

Read more →
ITGR
Jun 3, 2026
ITGRConferences/Events

Integer to Participate in Truist Securities 2026 MedTech Conference on June 16

Integer Holdings Corporation will participate in the Truist Securities 2026 MedTech Conference on June 16, 2026. The executive leadership team will engage in a fireside chat at 10:40 a.m. ET. A live webcast will be available on the company's Investor Relations website.

Read more →
ITGR
Apr 30, 2026
ITGRGeneral
▲ +5.8%on this news

Integer Holdings Corporation Reports First Quarter 2026 Results

Integer Holdings Corporation reported first quarter results for 2026, with sales rising 0.5% to $440 million. Despite a significant increase in GAAP income from continuing operations, operating income and adjusted metrics showed declines. The company anticipates returning to above-market organic sales growth in 2027 amid ongoing strategic reviews.

Read more →
ITGR
Apr 30, 2026
ITGRGeneral
▲ +5.8%on this news

Integer Announces Strategic Review to Maximize Stockholder Value

Integer Holdings Corporation announced a strategic review to explore options like a sale or merger to enhance stockholder value. The Board believes this is the right time to consider various opportunities, given the strong interest in the company. Integer's leadership remains confident in its strategy and growth potential.

Read more →
ITGR
Jan 10, 2024
ITGRGeneral

Integer Holdings Corporation Announces Preliminary Unaudited Sales Results and Acquisition of Pulse Technologies

Integer Holdings Corporation announced its preliminary unaudited sales results for 2023, indicating a 16% increase over the previous year. The company also completed the acquisition of Pulse Technologies, which brings advanced micro machining capabilities to strengthen its position in growing markets. The acquisition is expected to be beneficial, enhancing Integer's product development capabilities and manufacturing resources. The financial details of the transaction include an estimated purchase price of approximately $140 million and expected growth in sales and EBITDA from Pulse Technologies.

Read more →
ITGR
Jan 30, 2023
ITGRGeneral

FIRST AMENDMENT TO CREDIT AGREEMENT

Integer Holdings Corporation (ITGR) has amended its existing credit agreement as of January 30, 2023. The amendments involve updates to the capitalized terms and conditions, ensuring compliance with lender requirements. The agreement demonstrates a proactive approach by Integer to modify its obligations while maintaining strong relationships with lenders. This will potentially enhance their financial flexibility moving forward.

Read more →
ITGR
Jul 30, 2018
ITGRGeneral

HISTORICAL FINANCIAL INFORMATION 2017 by Quarter and Total Year - 5 periods 2018 by 1st Quarter - 1 period GENERAL Non-GAAP Financial Information Discontinued Operations Reporting Important Note Regarding Financial State

2017 by Quarter and Total Year - 5 periods 2018 by 1st Quarter - 1 period HISTORICAL FINANCIAL INFORMATION PRESENTED Operations Statements and GAAP to Non-GAAP Reconciliations Bridges To Previously Reported The Company uses non-GAAP financial measures, including the measures

Read more →
ITGR
Jul 2, 2018
ITGRGeneral

Integer Completes Divestiture of its Advanced Surgical and Orthopedics Product Lines FRISCO, TX

Integer Completes Divestiture of its Advanced Surgical and Orthopedics Product Lines FRISCO, TX July 02, 2018 Integer Holdings Corporation ( Integer ) (NYSE: ITGR) today announced that it has completed the previously announced sale of its Advanced Surgical and Orthopedics ( AS&

Read more →
ITGR
Jul 17, 2017
ITGRGeneral

Integer Announces Appointment of Joseph W. Dziedzic as President and Chief Executive Officer

Investor Relations: Amy Wakeham IR@ integer.net 214.618.4978 FOR IMMEDIATE RELEASE Media Relations: Kelly Butler kelly.butler@integer.net 214.618.4216 Integer Announces Appointment of Joseph W. Dziedzic as President and Chief Executive Officer FRISCO, TEXAS, July 17, 2017 - In

Read more →
ITGR
Mar 27, 2017
ITGRGeneral

Integer Announces Leadership Change

Integer Announces Leadership Change FRISCO, TEXAS, March 27, 2017 Integer Holdings Corporation (NYSE: ITGR), a leading medical device outsource (MDO) manufacturer, today announced that Thomas J. Hook has stepped down as Integer s President & Chief Executive Officer, effective i

Read more →
ITGR
Feb 27, 2017
ITGRGeneral

Gary Haire to Join Integer as Executive Vice President and Chief Financial Officer

Investor Relations: Amy Wakeham IR@ integer.net 214.618.4978 FOR IMMEDIATE RELEASE Media Relations: Kelly Butler kelly.butler@integer.net 214.618.4216 Gary Haire to Join Integer as Executive Vice President and Chief Financial Officer ~ Proven Executive Brings Strong Background

Read more →
ITGR
Apr 28, 2016
ITGRGeneral

LAKE REGION MEDICAL HOLDINGS, INC. Unaudited Condensed Consolidated Balance Sheets (in thousands, except per share data)

LAKE REGION MEDICAL HOLDINGS, INC. Unaudited Condensed Consolidated Balance Sheets (in thousands, except per share data) October 3, 2015 January 3, 2015 Assets Current assets: Cash $ 52,362 $ 44,191 Accounts receivable, net of allowances of $5,037 and

Read more →

About Integer Holdings Corporation

Plano, TX 11,000 employees integer.net
Headquarters5830 GRANITE PARKWAY., SUITE 1150, PLANO, TX, 75024
BIOPHARMAWATCH ELITE
Trade the next ITGR catalyst before the market reprices
Every FDA decision, PoA score, 13F move and dilution flag on this page, for 1,100+ biotech tickers. From $24/mo billed annually.
Cancel anytime